Related Experiment Video
Updated: Jul 10, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
RNAi in arthritis: prospects of a future antisense therapy in inflammation
Maroun Khoury1, Christian Jorgensen, Florence Apparailly
1Inserm U 844, INM Hôpital Saint Eloi, BP 74103, 80 rue Augustin Fliche, 34091 Montpellier cedex 5, France. khoury@montp.inserm.fr
Abstract:
Rheumatoid arthritis is a chronic autoimmune disease of unknown etiology that is characterized by chronic systemic inflammation, mainly affecting the joints, leading to subsequent destruction of the cartilage and bone. RNA interference (RNAi) has been used as a remarkable new research tool to control gene expression and is ultimately envisioned to be useful in clinical treatments. The potential application of RNAi-based therapy in rheumatoid disorders is evaluated. The first successful attempts at TNFalpha silencing by local and systemic delivery of small interfering RNA in experimental arthritic models are discussed. In addition, RNAi and current biotherapies used in the clinic are compared and contrasted.
Insights
RNA interference (RNAi) shows promise for treating rheumatoid arthritis by silencing tumor necrosis factor-alpha (TNFalpha). This gene-silencing approach, using small interfering RNA, is being explored as a novel therapy for autoimmune joint inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Rheumatoid arthritis is a chronic autoimmune disease causing joint inflammation and destruction.
- Unknown etiology contributes to the complexity of rheumatoid arthritis treatment.
- RNA interference (RNAi) is a powerful tool for gene expression control.
Purpose of the Study:
- To evaluate the potential of RNAi-based therapy for rheumatoid disorders.
- To discuss early successes in TNFalpha silencing using RNAi in arthritis models.
Main Methods:
- Utilized small interfering RNA (siRNA) for gene silencing.
- Investigated local and systemic delivery of siRNA in experimental arthritis models.
- Compared RNAi with existing biologic therapies.
Main Results:
- Demonstrated successful TNFalpha silencing via local and systemic siRNA delivery in experimental arthritis.
- Provided a comparative analysis of RNAi and current biotherapies.
Conclusions:
- RNA interference presents a promising therapeutic strategy for rheumatoid arthritis.
- Further research into RNAi delivery and efficacy is warranted for clinical application.
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Editing
Types of RNA
RNA Performs Diverse...